Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination with AMG 404 in Subjects with Small Cell Lung Cancer (SCLC)
NCT Number:
NCT04885998
Phase:
I
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Lung
Study Objectives:
The main purpose of this study is to evaluate the safety, tolerability, and recommended phase 2 target dose of AMG 757 in combination with AMG 404.
Study Documents
(MUSC NetID required for document access)